HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
GlobalData on MSN10d
HeartBeam submits 510(k) application to FDA for ECG software
HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...
HeartBeam seeks FDA nod for ECG synthesis software
SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...
Investing11d
HeartBeam vraagt FDA-goedkeuring aan voor ECG-synthesessoftware
SANTA CLARA, Californië - HeartBeam, Inc. (NASDAQ: BEAT), een pionier in medische technologie met een marktkapitalisatie van $56,5 miljoen die momenteel handelt tegen $2,12 per aandeel, heeft aangekon ...
Biomednewsbreaks Heartbeam Inc. (NASDAQ: BEAT) Submits FDA Application For 12-Lead ECG Synthesis Software
HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...
Le Lézard11d
Deepgram Accelerates Into 2025, Empowering 200,000+ Developers From Startups to Global Enterprises to Build Voice AI
Deepgram, the leading voice AI platform for developers building speech-to-text (STT), text-to-speech (TTS), and full speech-to-speech (STS) offerings, today announced record business growth and ...
Le Lézard11d
Medrio's Launches AI-Enabled Reporting, Tackling Increasing Data Challenges in Clinical Trials
Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled reporting, an innovative new capability available within Medrio CDMS/EDC. Medrio's AI-enabled reporting ...